Biocatalysts launches new enzyme panel for carbohydrate modification


03 Nov 2017 --- Biocatalysts has announced the launch of a new enzyme panel for the food industry, which is aimed at companies that are developing products to address the current trends of sugar reduction and soluble fiber inclusion. 

Biocatalysts has undertaken many enzyme projects to develop and manufacture exclusive carbohydrate modifying enzymes for customers in the food industry. Knowing that this is a major area for development in the food industry, Biocatalysts has developed a new panel of carbohydrate modifying enzymes that food scientists can use to aid product development in this space. This enzyme panel will consist of various small samples of enzymes which have been discovered to be specifically active on carbohydrates such as xylan, pectin and manan. These types of carbohydrates can be enzymatically modified to add value to various food applications. Examples of this include, building polymers and oligosaccharides from simple monomeric and dimeric sugars or reducing large complex carbohydrate polymers to smaller oligosaccharides for use as soluble fiber or bulking agents.

Biocatalysts will be displaying the new enzyme panels on their booth and will be running a competition for one lucky winner to take a panel away with them. To be in with a chance of winning, simply drop by Booth P50 in Hall 8 and leave a business card.

Alongside this new product launch, Biocatalysts will be showcasing their capabilities in enzyme discovery, development and manufacture, which responds to the need for unique enzymes in the food industry to drive innovation and differentiate products from your competitors. The process of taking a new enzyme from concept to routine manufacture has previously been an expensive and lengthy process, but Biocatalysts is continuously breaking down these barriers. The latest addition to Biocatalysts’ capabilities is their new MetXtra proprietary platform, which has further reduced the cost and time that it takes to identify, rationally select and produce novel enzyme samples for testing.  

Daren Bryce, Commercial Director at Biocatalysts comments: “With the food industry moving at a fast pace, innovation is key if food companies want to stay ahead of the game. There are a limited number of ingredients, processes and standard enzymes available and chances are, if you’re using them then so are your competitors. The ideal situation would be for food manufacturers to have access to unique solutions at a cost and timeframe that suits. This is where Biocatalysts come in.”   

Biocatalysts will be exhibiting at Food Ingredients Europe this year, which is being held in Frankfurt, Germany 28th – 30th November 17.

To contact our editorial team please email us at

Biocatalysts Ltd.


Innovation is at the core of Biocatalysts. Our culture is based on quality, customer service, technical knowledge and a desire to make positive changes (innovation). Innovation underpins our growth at Biocatalysts allowing us to better serve our customers and other stakeholders. All Biocatalysts staff make positive contributions to the generation and implementation of innovation ideas. These ideas result in improvements in our working environment, our process systems, our infrastructure and our methods of communication with customers, in addition to stimulating ideas for new enzyme products.

We also recognise, and are very appreciative of, the wealth of great ideas that are contributed to Biocatalysts Ltd from our valued customers, suppliers, technical contacts, University contacts and friends. Over the last 20 years we have worked closely with external contacts to harness and realise the power of innovation; our current strategy is to further foster these relationships and find new partners for innovation.

Related Articles

Business News

Biocatalysts reveals £6 million plant investment

27 Aug 2018 --- UK-based speciality enzyme company, Biocatalysts Ltd. has celebrated its 35th anniversary this year with a major investment into its future manufacturing capacity. Over £6 million (US$7.7 million) will be invested in total, comprising an 11,000 sq ft extension to the existing building which has just been completed. The next step is to fit out the building with cutting-edge equipment, including a 10m3 fermenter and down-stream processing machinery.

Business News

BRAIN acquires a majority stake in Biocatalysts

20 Mar 2018 --- Bio-economy company BRAIN AG (Biotechnology Research and Information Network AG) has announced the share purchase agreement between BRAIN and Biocatalysts Ltd. The takeover of the majority stake of Biocatalysts’s shares by BRAIN is governed and the transaction will be completed within the first quarter of 2018.

Food Ingredients News

Avoid Vanilla Disaster in Low Crop Year, Says Biocatalysts

18 Apr 2016 --- The vanilla crop in Madagascar this year is very poor and the impact is already becoming clear. The price has risen to more than $200/kg compared to $20/kg just 5 years ago and food processors are already being asked by industry experts to consider using less of this popular flavor in its many end applications. Depol 40L, an enzyme from UK and US based enzyme manufacturer Biocatalysts Ltd, may be the answer.

Food Ingredients News

Microbial Enzymes Open-up Italian Flavoured Enzyme Modified Cheese to Kosher & Halal Markets

21 Nov 2014 --- Animal pregastric esterase’s (PGEs) are easily available and widely used for Enzyme Modified Cheese (EMC) applications, mostly to produce an Italian-type flavour (e.g. Parmesan, Romano, Provolone). But what if you want to create an EMC suitable for vegetarian, kosher or halal markets?

Food Ingredients News

Biocatalysts Succeed in Manufacturing Customer’s Novel Food Enzyme Within 6 Months

24 Mar 2014 --- Speciality enzyme manufacturer, Biocatalysts Ltd, recently partnered with a food ingredient company that had developed a novel biocatalytic route for synthesis of a high value flavour compound. The biocatalyst was initially developed for the company by a Contract Research Organisation who did not have sufficient capacity or logistics to supply this enzyme on a routine basis.

More Articles